You are here

  • Home
  • Online First
  • Risk stratifying chest pain patients in the emergency department using HEART, GRACE and TIMI scores, with a single contemporary troponin result, to predict major adverse cardiac events

Article Text

Article menu

other Versions

Download PDFPDF
Original article
Risk stratifying chest pain patients in the emergency department using HEART, GRACE and TIMI scores, with a single contemporary troponin result, to predict major adverse cardiac events
  1. Peter D W Reaney1,
  2. Hamish I Elliot2,
  3. Awsan Noman3,
  4. Jamie G Cooper1
  1. 1Aberdeen Royal Infirmary, Emergency Department, Aberdeen, UK
  2. 2School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK
  3. 3Department of Cardiology, Aberdeen Royal Infirmary, Aberdeen, UK
  1. Correspondence to Dr Peter D W Reaney, Emergency Department, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK; peter.reaney{at}nhs.net

Abstract

Background The majority of patients presenting to the ED with cardiac sounding chest pain have a non-diagnostic ECG and the problem of differentiating those suffering an acute coronary syndrome from those without is familiar to all ED clinical staff. To stratify risk in these patients, specific scores have been developed. Recent work has focused on incorporating newer high-sensitivity cardiac troponin (hs-cTn) assays; however, issues regarding performance and availability of these assays remain.

Aim Prospectively compare HEART, Global Registry of Acute Coronary Events (GRACE) and Thrombolysis in Myocardial Infarction (TIMI) scores, using a single contemporary cTn at admission, to predict a major adverse cardiac event (MACE) at 30 days.

Method Prospective observational cohort study performed in a UK tertiary hospital in patients with suspected cardiac chest pain and no significant ST elevation on initial ECG. Data collection took place 2 December 2014 to 8 February 2016. The treating clinician recorded risk score data real time and a single contemporary cTn taken at presentation was used in score calculation. The primary endpoint was 30-day MACE. C-statistic was determined for each score and diagnostic characteristics of high-risk and low-risk cut-offs were calculated.

Results 189/1000 patients in the study developed a 30-day MACE. The c-statistic of HEART for 30-day MACE (0.87 (95% CI 0.84 to 0.90)) was higher than TIMI (0.78 (95% CI 0.74 to 0.81)) and GRACE (0.74 (95% CI 0.70 to 0.78)).

HEART score ≤3 identified low-risk patients with sensitivity 99.5% (95% CI 97.1% to 99.9%) and negative predictive value (NPV) 99.6% (95% CI 97.3% to 99.9%) exceeding TIMI 0 (sensitivity 97.4% (95% CI 93.9% to 99.1%) and NPV 97.8% (95% CI 94.8% to 99.1%)) and GRACE score 0–55 (sensitivity 95.2% (95% CI 91.1% to 97.8%) and NPV 95.8% (95% CI 92.2% to 97.7%)).

Conclusion HEART outperformed both TIMI and GRACE in overall discriminative capacity for 30-day MACE. Using a single contemporary cTn at presentation, a HEART score of ≤3 demonstrated sensitivity and NPV of ≥99.5% for 30-day MACE. These results reach the threshold for a safe discharge strategy but should be interpreted thoughtfully in light of other work.

  • emergency department
  • acute coronary syndrome
  • cardiac care, diagnosis
  • acute myocardial infarct
  • risk management

https://doi.org/10.1136/emermed-2017-207172

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors PDWR: planning, data collection, data recording, statistical analysis, writing and review. JGC: planning, data collection, data recording, endpoint review, statistical analysis, document writing and review. HIE: data collection, data recording, statistical analysis, document review. AN: endpoint review, document review.

    • Funding JGC was the recipient of NRS (National Research Scotland) Clinical Research Fellowship.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Author note This study was registered with the Institutional Quality, Governance and Risk Unit (Project ID 3293) and Caldicott guardian approval was obtained.